189 related articles for article (PubMed ID: 28197653)
1. Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation? : A planning study.
Botticella A; Defraene G; Nackaerts K; Deroose C; Coolen J; Nafteux P; Vanstraelen B; Joosten S; Michiels LAW; Peeters S; De Ruysscher D
Strahlenther Onkol; 2017 Apr; 193(4):285-294. PubMed ID: 28197653
[TBL] [Abstract][Full Text] [Related]
2. Tomotherapy PET-guided dose escalation: A dosimetric feasibility study for patients with malignant pleural mesothelioma.
Maggio A; Cutaia C; Di Dia A; Bresciani S; Miranti A; Poli M; Del Mastro E; Garibaldi E; Gabriele P; Stasi M
Strahlenther Onkol; 2016 Feb; 192(2):102-8. PubMed ID: 26453534
[TBL] [Abstract][Full Text] [Related]
3. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162
[TBL] [Abstract][Full Text] [Related]
4. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of volumetric-modulated arc therapy for malignant pleural mesothelioma.
Runxiao L; Yankun C; Lan W
J Appl Clin Med Phys; 2016 Mar; 17(2):139-144. PubMed ID: 27074478
[TBL] [Abstract][Full Text] [Related]
6. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
8. Tomotherapy in malignant mesothelioma: a planning study to establish dose constraints.
Leitzen C; Wilhelm-Buchstab T; Stumpf S; Heimann M; Koch D; Schmeel C; Simon B; Vornholt S; Garbe S; Röhner F; Schoroth F; Schild HH; Schüller H; Müdder T
Strahlenther Onkol; 2019 Jul; 195(7):668-676. PubMed ID: 30915490
[TBL] [Abstract][Full Text] [Related]
9. PET-guided dose escalation tomotherapy in malignant pleural mesothelioma.
Fodor A; Fiorino C; Dell'Oca I; Broggi S; Pasetti M; Cattaneo GM; Gianolli L; Calandrino R; Di Muzio NG
Strahlenther Onkol; 2011 Nov; 187(11):736-43. PubMed ID: 22037650
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
Krayenbuehl J; Riesterer O; Graydon S; Dimmerling P; Kloeck S; Ciernik IF
J Appl Clin Med Phys; 2013 Jul; 14(4):4130. PubMed ID: 23835378
[TBL] [Abstract][Full Text] [Related]
11. Compensator-based intensity-modulated radiation therapy for malignant pleural mesothelioma post extrapleural pneumonectomy.
Javedan K; Stevens CW; Forster KM
J Appl Clin Med Phys; 2008 Oct; 9(4):98-109. PubMed ID: 19020484
[TBL] [Abstract][Full Text] [Related]
12. Geometric dose prediction model for hemithoracic intensity-modulated radiation therapy in mesothelioma patients with two intact lungs.
Kuo L; Yorke ED; Dumane VA; Foster A; Zhang Z; Mechalakos JG; Wu AJ; Rosenzweig KE; Rimner A
J Appl Clin Med Phys; 2016 May; 17(3):371-379. PubMed ID: 27167294
[TBL] [Abstract][Full Text] [Related]
13. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
14. Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
Fodor A; Broggi S; Incerti E; Dell'Oca I; Fiorino C; Samanes Gajate AM; Pasetti M; Cattaneo MG; Passoni P; Gianolli L; Calandrino R; Picchio M; Di Muzio N
Clin Lung Cancer; 2019 Jan; 20(1):e29-e38. PubMed ID: 30253920
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric Comparison Between Helical Tomotherapy and Volumetric Modulated Arc Therapy in Patients With Malignant Pleural Mesothelioma.
Müdder T; Sarria GR; Henkenberens C; Holz J; Garbe S; Röhner F; Stumpf S; Buchstab T; Giordano FA; Leitzen C
Clin Oncol (R Coll Radiol); 2022 Mar; 34(3):164-171. PubMed ID: 34429236
[TBL] [Abstract][Full Text] [Related]
16. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
[TBL] [Abstract][Full Text] [Related]
17. Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
Krayenbuehl J; Hartmann M; Lomax AJ; Kloeck S; Hug EB; Ciernik IF
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):628-34. PubMed ID: 20385451
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic intensity-modulated radiation therapy (IMRT) and inverse treatment planning for advanced pleural mesothelioma. Feasibility and initial results.
Münter MW; Nill S; Thilmann C; Hof H; Höss A; Häring P; Partridge M; Manegold C; Wannenmacher M; Debus J
Strahlenther Onkol; 2003 Aug; 179(8):535-41. PubMed ID: 14509952
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment.
Lorentini S; Amichetti M; Spiazzi L; Tonoli S; Magrini SM; Fellin F; Schwarz M
Strahlenther Onkol; 2012 Mar; 188(3):216-25. PubMed ID: 22318326
[TBL] [Abstract][Full Text] [Related]
20. Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma.
Ulger S; Cetin E; Catli S; Sarac H; Kilic D; Bora H
Technol Cancer Res Treat; 2017 Jun; 16(3):332-338. PubMed ID: 28462689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
